Just in time for Valentine’s Day comes the Institute of Medicine’s new report, Countering the Problem of Falsified and Substandard Drugs.
Some relevant findings include:
· Congress should fund the FDA to do a national track and trace system, possibly using California as a model.
· The 50 states should adopt NABP's standards for wholesaler licensing (and revocation of license).
· The FDA should publish a list of wholesalers who have lost their licenses from states to, in effect, create a de facto national wholesaler blacklist.
· NIST should setup a repository of counterfeit detection technologies.
Lots of good information.
More good information (and insights) will be at hand at the February 28th conference, The Danger of False Profits: The Threat of Counterfeits to the Public Health. Jointly presented by the Center for Medicine in the Public Interest and the Institute for Policy Innovation, this event will feature speakers iSenior Counselor to the FDA Commissioner John Taylor, Jeff Gren, Director, Office of Health and Consumer Goods, U.S. Department of Commerce, John Clark, Vice President & Chief Security Officer, Pfizer, Michael Maves of Project Hope, Former Executive Vice President and CEO, American Medical Association, Gaurvika Nayyar Research Fellow and Analyst, National Institute of Health, among others.
Event Details:
Thursday, February 28, 2013
9:00 am - 2:00 pm
Reserve Officers Association Headquarters, 5th Floor
One Constitution Ave NE, Washington DC
*Complimentary lunch will be provided
Questions? Please contact Erin Humiston at (972) 874-5139, or erin@ipi.org